{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:11:39Z","timestamp":1772539899132,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1038\/s41433-022-02345-3","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:07:23Z","timestamp":1671282443000},"page":"2327-2334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8064-3545","authenticated-orcid":false,"given":"Reza","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanieh","family":"Pirankuraim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamim Taghvaei","family":"Javanshir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Bereimipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Taghvaei","family":"Javanshir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habibollah","family":"Mahmoodzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Nayernia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"key":"2345_CR1","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.4103\/ijo.IJO_721_20","volume":"68","author":"D Ancona-Lezama","year":"2020","unstructured":"Ancona-Lezama D, Dalvin LA, Shields CL. Modern treatment of retinoblastoma: A 2020 review. Indian J Ophthalmol. 2020;68:2356.","journal-title":"Indian J Ophthalmol"},{"key":"2345_CR2","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.3390\/cancers12082304","volume":"12","author":"R Kaewkhaw","year":"2020","unstructured":"Kaewkhaw R, Rojanaporn D. Retinoblastoma: etiology, modeling, and treatment. Cancers (Basel). 2020;12:2304.","journal-title":"Cancers (Basel)"},{"key":"2345_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/17469899.2018.1478729","volume":"13","author":"S Soliman","year":"2018","unstructured":"Soliman S, Kletke S, Roelofs K, VandenHoven C, Mckeen L, Gallie B. Precision laser therapy for retinoblastoma. Expert Rev Ophthalmol. 2018;13:149\u201359.","journal-title":"Expert Rev Ophthalmol"},{"key":"2345_CR4","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1177\/1120672120946285","volume":"31","author":"VS Vempuluru","year":"2021","unstructured":"Vempuluru VS, Jakati S, Kaliki S. Delayed metastasis in patients with intraocular retinoblastoma: A review of three cases. Eur J Ophthalmol. 2021;31:2042\u20137.","journal-title":"Eur J Ophthalmol"},{"key":"2345_CR5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ophtha.2020.09.032","volume":"128","author":"AS Tomar","year":"2021","unstructured":"Tomar AS, Finger PT, Gallie B, Kivel\u00e4 TT, Mallipatna A, Zhang C, et al. Global retinoblastoma treatment outcomes: Association with national income level. Ophthalmology. 2021;128:740\u201353.","journal-title":"Ophthalmology"},{"key":"2345_CR6","doi-asserted-by":"crossref","unstructured":"Shields CL, Lally SE. Retinoblastoma, in: Ocul Oncol, Springer, 2019: pp. 91\u201399.","DOI":"10.1007\/978-981-13-2336-2_10"},{"key":"2345_CR7","doi-asserted-by":"publisher","unstructured":"Chantada G, Schaiquevich P. Management of retinoblastoma in children: current status, pediatr. Drugs. (2015). https:\/\/doi.org\/10.1007\/s40272-015-0121-9.","DOI":"10.1007\/s40272-015-0121-9"},{"key":"2345_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/genes10110879","volume":"10","author":"JL Berry","year":"2019","unstructured":"Berry JL, Polski A, Cavenee WK, Dryja TP, Murphree AL, Gallie BL. The RB1 story: characterization and cloning of the first tumor suppressor gene. Genes (Basel). 2019;10:879.","journal-title":"Genes (Basel)"},{"key":"2345_CR9","doi-asserted-by":"publisher","first-page":"5571413","DOI":"10.1155\/2021\/5571413","volume":"2021","author":"S Tutunchi","year":"2021","unstructured":"Tutunchi S, Akhavan S, Bereimipour A, Hossein Ghaderian SM. Evaluation of important molecular pathways and candidate diagnostic biomarkers of noninvasive to invasive stages in gastric cancer by in silico analysis. J Oncol. 2021;2021:5571413.","journal-title":"J Oncol"},{"key":"2345_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2105-13-71","volume":"13","author":"D Wu","year":"2012","unstructured":"Wu D, Rice CM, Wang X. Cancer bioinformatics: A new approach to systems clinical medicine. BMC Bioinformatics. 2012:13:71.","journal-title":"BMC Bioinformatics"},{"key":"2345_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7717\/peerj.8873","volume":"1","author":"M Cao","year":"2020","unstructured":"Cao M, Wang S, Zou J, Wang W. Bioinformatics analyses of retinoblastoma reveal the retinoblastoma progression subtypes. Bioinforma GENOMICS. 2020;1:1\u201317. https:\/\/doi.org\/10.7717\/peerj.8873.","journal-title":"Bioinforma GENOMICS"},{"key":"2345_CR12","first-page":"234","volume":"0","author":"Y Zeng","year":"2020","unstructured":"Zeng Y, He T, Liu J, Li Z, Xie F, Chen C, et al. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma. Med (Baltim). 2020;0:234\u201341.","journal-title":"Med (Baltim)"},{"key":"2345_CR13","doi-asserted-by":"publisher","first-page":"e19952","DOI":"10.1097\/MD.0000000000019952","volume":"99","author":"J Huang","year":"2020","unstructured":"Huang J, Zhang L, Li Z, Lu X. Screening and identification of key biomarkers for retinoblastoma. Medicine (Baltimore). 2020;99:e19952.","journal-title":"Medicine (Baltimore)"},{"key":"2345_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00234-020-02538-1","volume":"63","author":"SJ Cho","year":"2021","unstructured":"Cho SJ, Kim JH, Baik SH, Sunwoo L, Bae YJ, Choi BS. Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis. Neuroradiology. 2021;63:499\u2013509.","journal-title":"Neuroradiology"},{"key":"2345_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/bjophthalmol-2018-313005","volume":"103","author":"A Gerrish","year":"2019","unstructured":"Gerrish A, Stone E, Clokie S, Ainsworth JR, Jenkinson H, McCalla M, et al. Non-invasive diagnosis of retinoblastoma using cell-free DNA from aqueous humour. Br J Ophthalmol. 2019;103:721\u20134.","journal-title":"Br J Ophthalmol"},{"key":"2345_CR16","first-page":"e28253","volume":"68","author":"S Patel","year":"2021","unstructured":"Patel S, Vogel J, Bradley K, Chuba PJ, Buchsbaum J, Krasin MJ. Rare tumors: Retinoblastoma, nasopharyngeal cancer, and adrenocorticoid tumors. Pediatr Blood\\Cancer. 2021;68:e28253.","journal-title":"Pediatr Blood\\Cancer"},{"key":"2345_CR17","doi-asserted-by":"crossref","unstructured":"Alzahem T, Alsarhani W, Albahlal A, Safieh LA, Aldahmash S. History and genetics of retinoblastoma, in: Retin. Present Futur., IntechOpen, 2019.","DOI":"10.5772\/intechopen.89035"},{"key":"2345_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/archophthalmol.2010.126","volume":"128","author":"KI Woo","year":"2010","unstructured":"Woo KI, Harbour JW. Review of 676 second primary tumors in patients with retinoblastoma: association between age at onset and tumor type. Arch Ophthalmol. 2010;128:865\u201370.","journal-title":"Arch Ophthalmol"},{"key":"2345_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejca.2020.04.005","volume":"133","author":"P Ketteler","year":"2020","unstructured":"Ketteler P, H\u00fclsenbeck I, Frank M, Schmidt B, J\u00f6ckel K-H, Lohmann DR. The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma. Eur J Cancer. 2020;133:47\u201355.","journal-title":"Eur J Cancer"},{"key":"2345_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","volume":"570","author":"AD Zuehlke","year":"2015","unstructured":"Zuehlke AD, Beebe K, Neckers L, Prince T. Regulation and function of the human HSP90AA1 gene. Gene. 2015;570:8\u201316.","journal-title":"Gene"},{"key":"2345_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0664-4","volume":"37","author":"X Xiao","year":"2018","unstructured":"Xiao X, Wang W, Li Y, Yang D, Li X, Shen C, et al. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. J Exp \\ Clin Cancer Res. 2018;37:1\u201313.","journal-title":"J Exp \\ Clin Cancer Res"},{"key":"2345_CR22","doi-asserted-by":"crossref","unstructured":"Xiao X, Wang W, Li X, Li Y, Yang D, Shen C, et al., MicroRNA-495 suppresses osteosarcoma invasion and migration by targeting HSP90AA1. Oncotarget. 2018;5.","DOI":"10.18632\/oncotarget.24048"},{"key":"2345_CR23","doi-asserted-by":"publisher","first-page":"11304","DOI":"10.1002\/jcp.27788","volume":"234","author":"Z Dong","year":"2019","unstructured":"Dong Z, Yang P, Qiu X, Liang S, Guan B, Yang H, et al. KCNQ1OT1 facilitates progression of non-small-cell lung carcinoma via modulating miRNA-27b-3p\/HSP90AA1 axis. J Cell Physiol. 2019;234:11304\u201314.","journal-title":"J Cell Physiol"},{"key":"2345_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0522-0","volume":"26","author":"M-J Young","year":"2019","unstructured":"Young M-J, Hsu K-C, Lin TE, Chang W-C, Hung J-J. The role of ubiquitin-specific peptidases in cancer progression. J Biomed Sci. 2019;26:1\u201314.","journal-title":"J Biomed Sci"},{"key":"2345_CR25","first-page":"116","volume":"8","author":"X Chen","year":"2021","unstructured":"Chen X, Dou QP, Liu J, Tang D. Targeting ubiquitin\u2014proteasome system with copper complexes for cancer therapy. Front Mol Biosci. 2021;8:116.","journal-title":"Front Mol Biosci"},{"key":"2345_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.62.10.3","volume":"62","author":"X Chen","year":"2021","unstructured":"Chen X, Chen S, Jiang Z, Gong Q, Tang D, Luo Q, et al. Ubiquitination-related miRNA\u2014mRNA interaction is a potential mechanism in the progression of retinoblastoma. Investig Ophthalmol\\Vis Sci. 2021;62:3.","journal-title":"Investig Ophthalmol\\Vis Sci"},{"key":"2345_CR27","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-18-0619","volume":"78","author":"M del Mar Maldonado","year":"2018","unstructured":"del Mar Maldonado M, Dharmawardhane S. Targeting rac and Cdc42 GTPases in cancer. Cancer Res. 2018;78:3101\u201311.","journal-title":"Cancer Res"},{"key":"2345_CR28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1158\/1541-7786.MCR-19-0726","volume":"18","author":"N Chernichenko","year":"2020","unstructured":"Chernichenko N, Omelchenko T, Deborde S, Bakst RL, He S, Chen C-H, et al. Cdc42 mediates cancer cell chemotaxis in perineural invasion. Mol Cancer Res. 2020;18:913\u201325.","journal-title":"Mol Cancer Res"},{"key":"2345_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01258-7","volume":"19","author":"S Zou","year":"2020","unstructured":"Zou S, Tong Q, Liu B, Huang W, Tian Y, Fu X. Targeting STAT3 in cancer immunotherapy. Mol Cancer. 2020;19:1\u201319.","journal-title":"Mol Cancer"},{"key":"2345_CR30","doi-asserted-by":"publisher","first-page":"173107","DOI":"10.1016\/j.ejphar.2020.173107","volume":"878","author":"T Gharibi","year":"2020","unstructured":"Gharibi T, Babaloo Z, Hosseini A, Abdollahpour-Alitappeh M, Hashemi V, Marofi F, et al. Targeting STAT3 in cancer and autoimmune diseases. Eur J Pharmacol. 2020;878:173107.","journal-title":"Eur J Pharmacol"},{"key":"2345_CR31","first-page":"739","volume":"39","author":"S Liu","year":"2018","unstructured":"Liu S, Zhang X, Hu C, Wang Y, Xu C. miR-29a inhibits human retinoblastoma progression by targeting STAT3 Corrigendum in\/10.3892\/or. 2021.8126. Oncol Rep. 2018;39:739\u201346.","journal-title":"Oncol Rep"},{"key":"2345_CR32","doi-asserted-by":"publisher","first-page":"152977","DOI":"10.1016\/j.prp.2020.152977","volume":"216","author":"L Wang","year":"2020","unstructured":"Wang L, Zhang Y, Xin X. Long non-coding RNA MALAT1 aggravates human retinoblastoma by sponging miR-20b-5p to upregulate STAT3. Pathol Pract. 2020;216:152977.","journal-title":"Pathol Pract"},{"key":"2345_CR33","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1080\/01635581.2020.1797835","volume":"73","author":"M Ono","year":"2021","unstructured":"Ono M, Takeshima M, Nishi A, Higuchi T, Nakano S. Genistein suppresses v-Src-driven proliferative activity by arresting the cell-cycle at G2\/M through increasing p21 level in Src-activated human gallbladder carcinoma cells. Nutr Cancer. 2021;73:1471\u20139.","journal-title":"Nutr Cancer"},{"key":"2345_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0908-8","volume":"17","author":"H Liu","year":"2018","unstructured":"Liu H, Bi J, Dong W, Yang M, Shi J, Jiang N, et al. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p\/G3BP2\/SRC\/FAK axis. Mol Cancer. 2018;17:1\u201319.","journal-title":"Mol Cancer"},{"key":"2345_CR35","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.1038\/s41388-019-0948-6","volume":"38","author":"M-Y Li","year":"2019","unstructured":"Li M-Y, Peng W-H, Wu C-H, Chang Y-M, Lin Y-L, Chang G-D, et al. PTPN3 suppresses lung cancer cell invasiveness by counteracting Src-mediated DAAM1 activation and actin polymerization. Oncogene. 2019;38:7002\u201316.","journal-title":"Oncogene"},{"key":"2345_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s43018-020-00135-y","volume":"2","author":"AC Watt","year":"2021","unstructured":"Watt AC, Cejas P, DeCristo MJ, Metzger-Filho O, Lam EYN, Qiu X, et al. CDK4\/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity. Nat Cancer. 2021;2:34\u201348.","journal-title":"Nat Cancer"},{"key":"2345_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Li J, Ou Y, Yang G, Deng K, Wang Q, et al. CDK4\/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism. Signal Transduct Target Ther. 2020;5:1\u201313.","journal-title":"Signal Transduct Target Ther"},{"key":"2345_CR38","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/cancers11081058","volume":"11","author":"P Gener","year":"2019","unstructured":"Gener P, Rafael D, Seras-Franzoso J, Perez A, Alamo Pindado L, Casas G, et al. Pivotal role of AKT2 during dynamic phenotypic change of breast cancer stem cells. Cancers (Basel). 2019;11:1058.","journal-title":"Cancers (Basel)"},{"key":"2345_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-020-01491-0","volume":"21","author":"T Liu","year":"2020","unstructured":"Liu T, Zhu J, Du W, Ning W, Zhang Y, Zeng Y, et al. AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma. Respir Res. 2020;21:1\u201315.","journal-title":"Respir Res"},{"key":"2345_CR40","doi-asserted-by":"publisher","first-page":"11188","DOI":"10.1002\/jcp.27768","volume":"234","author":"J Bertacchini","year":"2019","unstructured":"Bertacchini J, Mediani L, Beretti F, Guida M, Ghalali A, Brugnoli F, et al. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit. J Cell Physiol. 2019;234:11188\u201399.","journal-title":"J Cell Physiol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02345-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02345-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02345-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T19:05:34Z","timestamp":1690225534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02345-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2345"],"URL":"https:\/\/doi.org\/10.1038\/s41433-022-02345-3","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"29 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was supported by a part of grant of Tehran University of medical science [Projects Code: 99-1-115-47842; 1400-2-259-54530].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}